Brief: Reshape Lifesciences Received Notice From Nasdaq Indicating That Co Is Not In Compliance With $1.00 Minimum Bid Price Requirement
Oct 13 (Reuters) -
* RESHAPE LIFESCIENCES: ON OCTOBER 10, RECEIVED NOTICE FROM
NASDAQ INDICATING THAT CO IS NOT IN COMPLIANCE WITH $1.00
MINIMUM BID PRICE REQUIREMENT
Further company coverage: RSLS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vyome Holdings
See all newsBrief: Vyome - Appoints Jerry Leonard As CFO On August 27, 2026 - SEC Filing
Biopharma firm Vyome Holdings posts Q2 net loss
Vyome Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
Vyome Holdings Inc expected to post a loss of 19 cents a share - Earnings Preview
Brief: Vyome Strikes Deal With Impetis Biosciences, Opening A ~$57B Market Opportunity